Sociodemographic trends in prostate cancer: Insights from the all of Us research program
- 2 July 2026
- journal article
- Published by Oxford University Press (OUP) in JNCI Cancer Spectrum
- Vol. 10 (5)
Abstract
Background: Prostate cancer (PCa) disproportionately affects vulnerable populations. The All of Us Research Program (AoURP) is a database that aims to encapsulate the diversity of the U.S. To explore the utility of this dataset in assessing PCa disparities, we investigated whether treatment usage, disease progression, and genomic research participation vary across sociodemographic factors among AoURP participants with PCa. Methods: We identified AoURP participants with PCa. Genomic research participation in AoURP, treatment usage, time-to-treatment (TTT), and time-to-metastasis (TTM) were assessed by demographics and distance from a National Cancer Institute-designated comprehensive cancer center (NCIDCCC). Multivariable logistic regression and Cox proportional hazards regression were performed to evaluate treatment usage and TTT and TTM, respectively. Results: We observed lower genomic data availability in Black versus White patients (p < 0.001). In multivariable analyses, patients residing >80 miles from an NCIDCCC were less likely to receive ARPIs (OR = 0.30, 95% CI 0.14–0.66, p=.002) and BTAs (OR = 0.46, 95% CI 0.30–0.70, p<.001) but more likely to undergo prostatectomy (OR = 1.97, 95% CI 1.43–2.71, p<.001) than those <40 miles. These patients also initiated treatment faster (HR = 1.54, 95% CI 1.27–1.87, p<.001) and developed metastasis slower (HR = 0.58, 95% CI 0.40–0.86, p=.006). Black patients were less likely to receive radiation (OR = 0.45, 95% CI 0.23–0.88, p=.020), prostatectomy (OR = 0.65, 95% CI 0.44–0.96, p=.028), and BTAs (OR = 0.65, 95% CI 0.45–0.93, p=.018) than White patients. Conclusions: PCa treatment usage, disease progression, and genomic research participation varied between demographic populations. As AoURP matures, additional studies may leverage future data releases to confirm these findings.Keywords
Funding Information
- Center for Cancer Research, National Cancer Institute, National Institutes of Health Intramural Research (ZIA BC 010453)
This publication has 57 references indexed in Scilit:
- Genetic Services in Appalachia Conference SeriesAmerican Journal of Medical Genetics Part A, 2025
- Physician Reasons for or Against Treatment Intensification in Patients With Metastatic Prostate CancerJAMA Network Open, 2024
- Unraveling non‐participation in genomic research: A complex interplay of barriers, facilitators, and sociocultural factorsJournal of Genetic Counseling, 2023
- Racial disparities in Black men with prostate cancer: A literature reviewCancer, 2022
- Race does not predict skeletal‐related events and all‐cause mortality in men with castration‐resistant prostate cancerCancer, 2020
- Association of Sociodemographic and Health-Related Factors With Receipt of Nondefinitive Therapy Among Younger Men With High-Risk Prostate CancerJAMA Network Open, 2020
- Survival of African American and non‐Hispanic white men with prostate cancer in an equal‐access health care systemCancer, 2020
- Rural-urban differences in financial burden among cancer survivors: an analysis of a nationally representative surveySupportive Care in Cancer, 2019
- Racial Differences in the Surgical Care of Medicare Beneficiaries With Localized Prostate CancerJAMA Oncology, 2016
- Impact of care at comprehensive cancer centers on outcome: Results from a population‐based studyCancer, 2015